Expansion of induced pluripotent stem cells under consideration of bioengineering aspects: part 1
Applied Microbiology and Biotechnology · 2025
DOI: 10.1007/s00253-024-13372-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, 2025. Verfasst von Samuel Lukas Schneider und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cell Cultivation Techniques, Tissue Engineering, and Medical Biology, Institute of Chemistry and Biotechnology, ZHAW Zurich University of …. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Cell Culture Techniques, Bioengineering. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
To fully utilize the potential of human induced pluripotent stem cells (hiPSCs) for allogeneic stem cell–based therapies, efficient and scalable expansion procedures must be developed. For other adherent human cell types, the combination of microcarriers (MCs) and stirred tank bioreactors has been shown to meet these demands. In this study, a hiPSC quasi-perfusion expansion procedure based on MCs was developed at 100-mL scale in spinner flasks. Process development began by assessing various medium exchange strategies and MC coatings, indicating that the hiPSCs tolerated the gradual exchange of medium well when cultivated on Synthemax II–coated MCs. This procedure was therefore scaled-up to the 1.3-L Eppendorf BioBLU 1c stirred tank bioreactor by applying the lower limit of Zwietering’s suspension criterion ( $${N}_{s1u}$$ N s 1 u ), thereby demonstrating proof-of-concept when used in combination with hiPSCs for the first time. To better understand the bioreactor and its bioengineering characteristics, computational fluid dynamics and bioengineering investigations were performed prior to hiPSC cultivation. In this manner, improved process understanding allowed an expansion factor of ≈ 26 to be achieved, yielding more than 3 × 10 9 cells within 5 days. Further quality analyses confirmed that the hiPSCs maintained their viability, identity, and differentiation potential throughout cultivation. Key points • $${N}_{s1u}$$ N s 1 u can be used as a scale-up criterion for hiPSC cultivations in MC-operated stirred bioreactors • Uniform distribution and attachment of cells to the MCs are crucial for efficient expansion • Perfusion is advantageous and supports the cultivation of hiPSCs
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Cell Cultivation Techniques, Tissue Engineering, and Medical Biology, Institute of Chemistry and Biotechnology, ZHAW Zurich University of Applied Sciences, Grüentalstrasse 14, 8820, Wädenswil, Switzerland.
- Advanced Manufacturing-Platform Engineering & Support, Bayer AG, Kaiser-Wilhelm-Allee 1, 51373, Leverkusen, Germany.
- Advanced Manufacturing-Platform Engineering & Support, Bayer AG, Kaiser-Wilhelm-Allee 1, 51373, Leverkusen, Germany. marcos.sousa1@bayer.com.
Zitieren
APA
Schneider, S. L., Teale, M. A., Seidel, S., Krasenbrink, J., Poggel, M., Eibl, D., Sousa, M. F. Q., & Eibl, R. (2025). Expansion of induced pluripotent stem cells under consideration of bioengineering aspects: part 1. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-024-13372-3
Vancouver
Schneider SL, Teale MA, Seidel S, Krasenbrink J, Poggel M, Eibl D, et al. Expansion of induced pluripotent stem cells under consideration of bioengineering aspects: part 1. Applied Microbiology and Biotechnology. 2025. doi:10.1007/s00253-024-13372-3
BibTeX
@article{Schneider2025,
author = {Schneider, Samuel Lukas and Teale, Misha Alexander and Seidel, Stefan and Krasenbrink, Jürgen and Poggel, Martin and Eibl, Dieter and Sousa, Marcos F Q and Eibl, Regine},
title = {Expansion of induced pluripotent stem cells under consideration of bioengineering aspects: part 1},
journal = {Applied Microbiology and Biotechnology},
year = {2025},
doi = {10.1007/s00253-024-13372-3}
}
EUVIMED